Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

Analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALAGet Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12. The stock has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.02.

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Recommended Stories

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.